Tag Archives: Bavarian Nordic

Danish drugmaker Bavarian Nordic announced on Friday that it is seeking European approval to use its mpox vaccine in children aged 12 to 17. This comes after the World Health Organization (WHO) declared the rapid spread of the new, more dangerous pox strain, Clade 1b, a public health emergency of international concern. Bavarian Nordic’s vaccine is currently approved for people …

Read More »